Trial site
Śląskie Centrum Chorób Serca w Zabrzu
Zabrze, 41-800, PolandEU-13 widening countryNot linked to an institution yet
- 16running trials
- 3closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Phase
- Phase 310 trials
- Phase 46 trials
- Phase 22 trials
- Status
- Recruiting10 trials
- Active, not recruiting4 trials
- Completed2 trials
- Not yet recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- Novo Nordisk A/S3 trials
- Acesion Pharma1 trial
- Actelion1 trial
- Anthos Therapeutics, Inc.1 trial
- AstraZeneca1 trial
- and 12 more
Running trials
Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001· Phase 3· Novo Nordisk A/S· Source
Recruiting
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
NCT07195149· Phase 3· Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.· Source
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
NCT07267949· Phase 2· Acesion Pharma· Source
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362· Phase 2· Novo Nordisk A/S· Source
Recruiting
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
NCT06929806· Phase 3· Pharmacosmos A/S· Source
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
NCT06677060· Phase 3· AstraZeneca· Source
Recruiting
Sacubitril/Valsartan in prevention of heart damage during breast cancer
treatment
2024-517804-12-00· Phase 3· Slaskie Centrum Chorob Serca W Zabrzu· Source
Recruiting
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
NCT05665608· Charite University, Berlin, Germany· Source
Contact: Gerhard Hindricks, Prof
Recruiting
The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction
NCT05508035· Phase 3· John Paul II Hospital, Krakow· Source
Active, not recruiting
HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation.
NCT05636176· Phase 3· Novo Nordisk A/S· Source
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200· Phase 3· Anthos Therapeutics, Inc.· Source
Active, not recruiting
Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
NCT04654988· Phase 4· Medical University of Warsaw· Source
Not yet recruiting
Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events following Left
Atrial Appendage Closure – Chronic Kidney Disease (SAFE LAAC CKD). Comparative Health
Effectiveness Ancillary Study – PILOT
NCT05660811· Phase 4· Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy· Source
Recruiting
Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion
NCT05759078· Phase 4· Wroclaw Medical University· Source
Contact: Marta Duda-Sikuła
Active, not recruiting
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
NCT04175600· Phase 3· Actelion· Source
Recruiting
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
NCT03445949· Phase 4· National Institute of Cardiology, Warsaw, Poland· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error